Dazmegrel
Code | Size | Price |
---|
TAR-T31213-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T31213-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T31213-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Dazmegrel (UK 38,485) is a highly potent and specific inhibitor of thromboxin A2 (TXA2) synthase.
CAS:
76894-77-4
Formula:
C16H17N3O2
Molecular Weight:
283.331
Purity:
0.98
SMILES:
Cc1c(Cn2ccnc2)c2ccccc2n1CCC(O)=O
References
1. Kemppainen BW, Urry DW, Luan CX, Xu J, Swaim SF, Goel S. In vitro skin penetration of dazmegrel delivered with a bioelastic matrix. Int J Pharm. 2004 Mar 1;271(1-2):301-3. PubMed PMID: 15129998.
2. D'Souza RJ, Phillips HM, Radeke HH, Aber GM, Strange RC. Mesangial cell DNA synthesis induced by hydrogen peroxide, interleukin-6, and platelet-derived growth factor: effects of indomethacin and dazmegrel. Nephron. 1996;72(2):263-8. PubMed PMID: 8684537.
3. Norris LA, Sheppard BL, Bonnar J. Increased whole blood platelet aggregation in normal pregnancy can be prevented in vitro by aspirin and dazmegrel (UK38485). Br J Obstet Gynaecol. 1992 Mar;99(3):253-7. PubMed PMID: 1606123.
4. Salinas P, Barrig?n S. Protective effects of dazmegrel on the PAF potential of ouabain-induced cardiac arrhythmias. Eur J Pharmacol. 1991 Dec 10;209(1-2):105-7. PubMed PMID: 1814756.